Financial News Based On Company



Advertisement

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors - Maravai LifeSciences ( NASDAQ:MRVI )

https://www.benzinga.com/pressreleases/25/06/g45834573/maravai-lifesciences-appoints-bernd-brust-as-chief-executive-officer-and-member-of-its-board-of-di
SAN DIEGO, June 09, 2025 ( GLOBE NEWSWIRE ) -- Maravai LifeSciences Holdings, Inc. MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the appointment of Bernd Brust as Chief Executive Officer ( CEO ) and a member of the Board of ...

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors

https://www.globenewswire.com/news-release/2025/06/09/3095837/0/en/Maravai-LifeSciences-Appoints-Bernd-Brust-as-Chief-Executive-Officer-and-Member-of-its-Board-of-Directors.html
SAN DIEGO, June 09, 2025 ( GLOBE NEWSWIRE ) -- Maravai LifeSciences Holdings, Inc. ( NASDAQ: MRVI ) , a global provider of life science reagents and services to researchers and biotech innovators, today announced the appointment of Bernd Brust as Chief Executive Officer ( CEO ) and a member of ...

Why Is Charles River ( CRL ) Down 0.1% Since Last Earnings Report?

https://www.zacks.com/stock/news/2487668/why-is-charles-river-crl-down-01-since-last-earnings-report
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Teladoc ( TDOC ) Down 0.1% Since Last Earnings Report?

https://www.zacks.com/stock/news/2479723/why-is-teladoc-tdoc-down-01-since-last-earnings-report
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GREGORY SUMME Takes a Bullish Stance: Acquires $375K In Avantor Stock - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/news/25/05/45647384/gregory-summe-takes-a-bullish-stance-acquires-375k-in-avantor-stock
A significant insider buy by GREGORY SUMME, Director at Avantor AVTR, was executed on May 27, and reported in the recent SEC filing. What Happened: SUMME demonstrated confidence in Avantor by purchasing 30,000 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission ...
Advertisement

Advertisement

Avantor Board Member Makes $253K Stock Purchase - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/news/25/05/45589874/avantor-board-member-makes-253k-stock-purchase
A significant insider buy by GREGORY SUMME, Board Member at Avantor AVTR, was executed on May 22, and reported in the recent SEC filing. What Happened: SUMME's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 20,000 ...

Top 2 Health Care Stocks That May Implode In Q2 - Hafnia ( NYSE:HAFN ) , LifeMD ( NASDAQ:LFMD )

https://www.benzinga.com/trading-ideas/short-ideas/25/05/45586351/top-2-health-care-stocks-that-may-implode-in-q2
As of May 23, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...

Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...' - Avantor ( NYSE:AVTR )

https://www.benzinga.com/general/health-care/25/04/45079557/goldman-sachs-downgrades-avantor-as-shares-spiral-60-since-2021-we-wrongly-assumed
Avantor Q1 sales fell 6% YoY to $1.58 billion, missing estimates; organic sales declined 2%. Goldman Sachs cut Avantor to Neutral, slashing the price target from $23 to $14 amid margin and growth concerns. Feel unsure about the market's next move?

Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday - Arhaus ( NASDAQ:ARHS ) , Amazon.com ( NASDAQ:AMZN )

https://www.benzinga.com/25/04/45065334/amazon-com-to-253-here-are-10-top-analyst-forecasts-for-tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc cut Boot Barn Holdings, Inc. BOOT price target from $190 to $165.

Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y

https://www.zacks.com/stock/news/2457026/avantor-stock-declines-despite-q1-earnings-in-line-revenues-down-yy
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
Advertisement

Advertisement

Avantor Analysts Cut Their Forecasts After Q1 Results - Avantor ( NYSE:AVTR )

https://www.benzinga.com/25/04/45038680/avantor-analysts-cut-their-forecasts-after-q1-results
Avantor Inc AVTR reported in-line earnings for its first quarter on Friday. The company posted adjusted EPS of 23 cents in line with consensus. The life science tools company reported sales of $1.58 billion, missing the consensus of $1.61 billion.

This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday - Adecoagro ( NYSE:AGRO ) , Avantor ( NYSE:AVTR )

https://www.benzinga.com/25/04/45037847/this-eli-lilly-analyst-turns-bearish-here-are-top-4-downgrades-for-monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift - Avantor ( NYSE:AVTR )

https://www.benzinga.com/general/health-care/25/04/45014623/avantor-sees-steady-earnings-plans-leadership-change-and-strategy-shift
Avantor Q1 sales fell 6% to $1.58 billion, missing estimates by $30 million. CEO Stubblefield to step down as cost savings target rises to $400 million. Today's manic market swings are creating the perfect setup for Matt's next volatility trade. Get his next trade alert for free, right here.

Avantor, Inc. ( AVTR ) Q1 Earnings Meet Estimates

https://www.zacks.com/stock/news/2455569/avantor-inc-avtr-q1-earnings-meet-estimates
Avantor (AVTR) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Danaher ( DHR ) Surpasses Q1 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2452411/danaher-dhr-surpasses-q1-earnings-and-revenue-estimates
Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Advertisement

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer - Lifecore Biomedical ( NASDAQ:LFCR )

https://www.benzinga.com/pressreleases/25/04/g44785208/lifecore-biomedical-appoints-thomas-d-salus-as-chief-legal-and-administration-officer
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore's Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

https://www.globenewswire.com/news-release/2025/04/14/3060792/23089/en/Lifecore-Biomedical-Appoints-Thomas-D-Salus-as-Chief-Legal-and-Administration-Officer.html
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry ...

Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030 - The Insight Partners

https://www.benzinga.com/pressreleases/25/04/g44647243/microbial-identification-methods-market-forecasted-to-grow-at-6-64-cagr-reaching-8-16-billion-by-2
US & Canada, April 04, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Apr, 02, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Microbial Identification Methods Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity ...

Here's Why You Should Hold AVTR Stock in Your Portfolio for Now

https://www.zacks.com/stock/news/2436284/heres-why-you-should-hold-avtr-stock-in-your-portfolio-for-now
Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

https://www.globenewswire.com/news-release/2025/03/18/3044982/0/en/Maravai-Lifesciences-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
Schedules Conference Call for Thursday, March 20, 2025 Schedules Conference Call for Thursday, March ...
Advertisement

Advertisement

Protection Reagents Market is Expected to Reach at US$ 329.0 Million by 2035, Exhibiting 5.5% CAGR | Fact.MR Analysis

https://www.benzinga.com/pressreleases/25/03/g44103252/protection-reagents-market-is-expected-to-reach-at-us-329-0-million-by-2035-exhibiting-5-5-cagr-fa
Rockville, MD , March 04, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the Protection Reagents Market was valued at US$ 182.6 million in 2024 and is expected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2035.

Silicone Rubber Color Paste Market is Projected to Reach at a US$ 444.6 Million by 2035, with a CAGR of 4.8% | Fact.MR Report

https://www.benzinga.com/pressreleases/25/03/g44072760/silicone-rubber-color-paste-market-is-projected-to-reach-at-a-us-444-6-million-by-2035-with-a-cagr
Rockville, MD , March 03, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global Silicone Rubber Colour Paste Market is estimated to reach a valuation of US$ 278.2 million in 2025 and is expected to grow at a CAGR of 4.8% during the ...

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook - Repligen ( NASDAQ:RGEN )

https://www.benzinga.com/25/02/43861240/repligens-q4-earnings-beat-2025-guidance-highlights-market-growth
Repligen Q4 EPS of $0.44 beat the $0.41 estimate, while revenue of $167.55 million was in line with forecasts. 2025 sales guidance set at $685 million-$710 million vs. $694.9 million consensus, with organic growth of 9.5%-13.5%.

Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand

https://www.zacks.com/stock/news/2413020/avantor-stock-declines-despite-q4-earnings-beat-margins-expand
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.

Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025 - Avantor ( NYSE:AVTR )

https://www.benzinga.com/25/02/43560312/life-science-tools-firm-avantor-reports-mixed-q4-earnings-forecasts-organic-sales-growth-in-2025
Avantor reported Q4 net sales of $1.69 billion, down 2% YoY, missing estimates. Adjusted EPS was $0.27, beating the consensus of $0.26. Net income surged to $500.4 million. The company forecasts 2025 organic revenue growth of 1%-3%. Brand New Membership Level: Benzinga Trade Alerts
Advertisement

Advertisement

Avantor, Inc. ( AVTR ) Surpasses Q4 Earnings Estimates

https://www.zacks.com/stock/news/2411762/avantor-inc-avtr-surpasses-q4-earnings-estimates
Avantor (AVTR) delivered earnings and revenue surprises of 8% and 1.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate CVS Health ( CVS ) to Report a Decline in Earnings: What to Look Out for

https://www.zacks.com/stock/news/2410213/analysts-estimate-cvs-health-cvs-to-report-a-decline-in-earnings-what-to-look-out-for
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Perchloric Acid Market is Expected to Expand at 3.4% CAGR, Reaching US$ 1,520.8 Million by 2034 | Fact.MR Report

https://www.benzinga.com/pressreleases/25/02/g43429527/perchloric-acid-market-is-expected-to-expand-at-3-4-cagr-reaching-us-1-520-8-million-by-2034-fact-
Rockville, MD , Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- The global perchloric acid market was valued at US$ 1,088.6 million in 2024 and has been forecasted to expand at a noteworthy CAGR of 3.4% to end up at US$ 1,520.8 Million by 2034.

Avantor, Inc. ( AVTR ) Q4 Earnings Preview: What's in the Cards?

https://www.zacks.com/stock/news/2407629/avantor-inc-avtr-q4-earnings-preview-whats-in-the-cards
Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance Health ( ELV ) Q4 Earnings and Revenues Beat Estimates

https://www.zacks.com/stock/news/2401865/elevance-health-elv-q4-earnings-and-revenues-beat-estimates
Elevance Health (ELV) delivered earnings and revenue surprises of 1.05% and 0.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Advertisement

( AVTR ) - Analyzing Avantor's Short Interest - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/short-sellers/25/01/43065267/avtr-analyzing-avantors-short-interest
Avantor's AVTR short percent of float has risen 20.78% since its last report. The company recently reported that it has 29.57 million shares sold short, which is 4.36% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.66 days to cover their ...

Strength Seen in CareDx ( CDNA ) : Can Its 6.1% Jump Turn into More Strength?

https://www.zacks.com/stock/news/2396244/strength-seen-in-caredx-cdna-can-its-61-jump-turn-into-more-strength
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

MD vs. AVTR: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2396026/md-vs-avtr-which-stock-is-the-better-value-option
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group ( MD Quick QuoteMD - ) and Avantor, Inc. ( AVTR Quick QuoteAVTR - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

How Is The Market Feeling About Avantor? - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/short-sellers/25/01/42756327/how-is-the-market-feeling-about-avantor
Avantor's AVTR short percent of float has fallen 9.07% since its last report. The company recently reported that it has 24.52 million shares sold short, which is 3.61% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.08 days to cover their ...

MD vs. AVTR: Which Stock Should Value Investors Buy Now?

https://www.zacks.com/stock/news/2388925/md-vs-avtr-which-stock-should-value-investors-buy-now
MD vs. AVTR: Which Stock Is the Better Value Option?
Advertisement

Advertisement

Quantum-Si Strengthens Global Footprint With Expanded Partner Network - Quantum-Si ( NASDAQ:QSI )

https://www.benzinga.com/24/12/42456884/quantum-si-strengthens-global-footprint-with-expanded-partner-network
Quantum-Si Incorporated QSI shares are trading higher premarket on Thursday. The company expanded its international distribution network to 15 partners. This expansion includes further growth in Western and Eastern Europe, Asia, and new markets in the Middle East, Africa, South America, and the ...

MD or AVTR: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2382295/md-or-avtr-which-is-the-better-value-stock-right-now
MD vs. AVTR: Which Stock Is the Better Value Option?

( AVTR ) - Analyzing Avantor's Short Interest - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/short-sellers/24/11/42216205/avtr-analyzing-avantors-short-interest
Avantor's AVTR short percent of float has risen 37.83% since its last report. The company recently reported that it has 31.90 million shares sold short, which is 4.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.62 days to cover their ...

MD or AVTR: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2374856/md-or-avtr-which-is-the-better-value-stock-right-now
MD vs. AVTR: Which Stock Is the Better Value Option?

Quantum-Si Shares Slip After Next-Gen Proteomics Platforms Are Unveiled - Quantum-Si ( NASDAQ:QSI )

https://www.benzinga.com/news/contracts/24/11/42114649/quantum-si-shares-slip-after-next-gen-proteomics-platforms-are-unveiled
Quantum-Si Inc QSI shares tanked over 12.8% Thursday morning. The company plans to introduce Platinum Pro, an advanced version of its Platinum platform, in the first half of 2025. Platinum Pro will feature a streamlined workflow, reducing hands-on time and speeding up processing.
Advertisement

Advertisement

Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results - PainReform ( NASDAQ:PRFX ) , Forte Biosciences ( NASDAQ:FBRX )

https://www.benzinga.com/news/earnings/24/11/42097113/crude-oil-moves-lower-williams-sonoma-shares-gain-after-q3-results
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 100 points on Wednesday. The Dow traded down 0.27% to 43,153.13 while the NASDAQ fell 0.88% to 18,820.86. The S&P 500 also fell, dropping, 0.63% to 5,879.70. Health care shares rose by 0.7% on ...

Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views - PainReform ( NASDAQ:PRFX ) , Forte Biosciences ( NASDAQ:FBRX )

https://www.benzinga.com/24/11/42095162/nasdaq-tumbles-over-100-points-tjx-earnings-top-views
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by more than 100 points on Wednesday. The Dow traded down 0.18% to 43,188.94 while the NASDAQ fell 0.71% to 18,853.10. The S&P 500 also fell, dropping, 0.64% to 5,879.40. Energy shares rose by 0.4% on Wednesday.

Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis - NVIDIA ( NASDAQ:NVDA ) , Quantum-Si ( NASDAQ:QSI )

https://www.benzinga.com/general/health-care/24/11/42091430/nvidia-partners-with-quantum-si-to-advance-single-molecule-analysis
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platform, Proteus, and advance Quantum-Si's core technologies of amino acid binders and ...

US Stocks Mostly Lower; Target Posts Downbeat Earnings - Target ( NYSE:TGT )

https://www.benzinga.com/24/11/42090547/us-stocks-mostly-lower-target-posts-downbeat-earnings
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling by more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 43,245.35 while the NASDAQ fell 0.36% to 18,918.89. The S&P 500 also rose, gaining, 0.28% to 5,900.34.

( AVTR ) - Analyzing Avantor's Short Interest - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/short-sellers/24/11/41848764/avtr-analyzing-avantors-short-interest
Avantor's AVTR short percent of float has fallen 7.92% since its last report. The company recently reported that it has 33.09 million shares sold short, which is 4.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.34 days to cover their ...
Advertisement

Advertisement

MD vs. AVTR: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2366650/md-vs-avtr-which-stock-is-the-better-value-option
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group ( MD Quick QuoteMD - ) or Avantor, Inc. ( AVTR Quick QuoteAVTR - ) . But which of these two companies is the best option for those looking for undervalued stocks?

How Is The Market Feeling About Avantor? - Avantor ( NYSE:AVTR )

https://www.benzinga.com/insights/short-sellers/24/11/41785949/how-is-the-market-feeling-about-avantor
Avantor's AVTR short percent of float has fallen 7.92% since its last report. The company recently reported that it has 33.09 million shares sold short, which is 4.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.34 days to cover their ...

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down

https://www.zacks.com/stock/news/2358946/avantors-stock-declines-despite-q3-earnings-beat-margins-down
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.

Avantor, Inc. ( AVTR ) Beats Q3 Earnings Estimates

https://www.zacks.com/stock/news/2357482/avantor-inc-avtr-beats-q3-earnings-estimates
Avantor (AVTR) delivered earnings and revenue surprises of 4% and 0.57%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

AVTR Stock Flat Following the Close of Divestiture Deal With Audax

https://www.zacks.com/stock/news/2354281/avtr-stock-flat-following-the-close-of-divestiture-deal-with-audax
Avantor closes its deal with Audax to divest its clinical services business.
Advertisement

Advertisement

Advertisement